A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

by Ceiler, J., Christopoulos, P., Daniel-Moreno, A., Elshiaty, M., Ferry, Q., Feufel, J., Heuvelman, M., Hinkfoth, F., Hofmann, S., Horos, R., Jehn, J., Kahraman, M., Kittner, P., Lusky, F., Mercaldo, N., Muley, T., Nötzel, D., Pelea, O., Rabe, K.F, Rajakumar, T., Reck, M., Sauka-Spengler, T., Schenz, J., Schindler, H., Sikosek, T., Skottke, J., Steinkraus, B.R, Thomas, M., Tikk, K., Uhle, F., Uhle, S., Weigand, M.A, Wu, Q.
Published 2022